Sleeve Gastrectomy to Roux-en-Y Gastric Bypass Conversion

Sleeve gastrectomy (SG) is the most commonly performed bariatric operation in the world, but it is not always a final destination — more than 20% of sleeve patients ultimately require a revisional procedure for weight regain, inadequate weight loss, or gastroesophageal reflux disease (GERD) (Małczak et al., Obesity Reviews, 2025). When conversion is needed, the Roux-en-Y gastric bypass (RYGB) is by far the most common choice: in the 2020 MBSAQIP national database, 86.2% of all sleeve conversions were to RYGB, performed most often for GERD (48.4%) followed by weight regain/inadequate weight loss (41.9%) (Clapp et al., SOARD, 2024).

Converting a sleeve to a gastric bypass means reshaping the existing sleeve into a small gastric pouch and connecting it to a Roux limb of small intestine. RYGB is the long-established "gold standard" of bariatric surgery, and because a sleeve has already been created, the pouch can often be fashioned with less technical difficulty than a primary bypass (Dang et al., Obesity Surgery, 2023). It is uniquely well suited to this role because it usually resolves reflux — the single biggest weakness of the sleeve — and adds moderate malabsorption for further weight loss (Matar et al., Obesity Surgery, 2021). As with all bariatric care, durable results depend on being embedded in a multidisciplinary program, and these reoperations are best performed at experienced, high-volume centers (Dang et al., 2023).

RYGB produces its effect through two combined mechanisms. First, the sleeve is reshaped into a small gastric pouch, which restricts the amount of food that can be eaten. Second, the small intestine is rerouted so a segment is bypassed, adding moderate malabsorption and favorable gut-hormone changes that reduce hunger and improve glucose metabolism (Dang et al., 2023). Critically, the bypass diverts acid and bile away from the esophagus and creates a small, low-pressure, rapid-emptying gastric reservoir — the opposite of the narrow, high-pressure tube left by a sleeve — which is why it is the most reliable antireflux conversion (Thá Nassif et al., Obesity Surgery, 2025). Because the sleeve is purely restrictive, converting to a bypass adds genuinely new malabsorptive and hormonal mechanisms rather than simply re-restricting the stomach (Matar et al., 2021).

• Highly effective reflux control — RYGB is considered the gold standard for refractory GERD after a sleeve, with symptom resolution reported between 60% and 100% across studies (Rapolti et al., J Laparoendosc Adv Surg Tech, 2024). In a randomized trial, bypass was objectively superior to the sleeve at preventing acid reflux and esophagitis (Lorentzen et al., Gastroenterology, 2021).

• Durable additional weight loss for weight-regain patients — in a single-center series, BMI fell from 43.4 to 32.1 at 12 months with excess BMI loss sustained above 48% beyond 4 years (Frieder et al., SOARD, 2026).

• A low complication profile for a revision — the overall serious-complication rate is about 7.2%, with mortality no different from a primary bypass (Dang et al., 2023).

• Technically more straightforward than other revisions — because a sleeve already exists, creating the pouch can be less difficult than in a primary bypass, and sleeve patients tend to have lower BMI and fewer comorbidities at conversion (Dang et al., 2023).

• Strong comorbidity resolution — conversion resolves hypertension and sleep apnea and frees many diabetic patients from medication (Yorke et al., American Journal of Surgery, 2017).

• The most proven, best-studied sleeve conversion — RYGB is the most widely used and extensively documented revisional procedure after a failed sleeve (Clapp et al., 2024).

Sleeve-to-bypass conversion is particularly well suited to patients with a prior sleeve gastrectomy who have:

• Refractory or de novo GERD — the strongest indication, and the situation where bypass clearly outperforms re-sleeve or a malabsorptive conversion; de novo GERD develops in up to 48% of patients over long-term follow-up after a sleeve (Dang et al., 2023).

• Significant weight regain or inadequate weight loss after the sleeve, especially in patients with a BMI below 40 at the time of conversion, who tend to achieve better results (Marwaha et al., Surgical Endoscopy, 2025).

• Functional complications of the sleeve, such as a stricture or stenosis, torsion, or dysphagia (Frieder et al., 2026).

• Metabolic disease such as type 2 diabetes, hyperlipidemia, or hypertension, where the bypass delivers strong metabolic benefit (Yorke et al., 2017).

• Willingness to commit to lifelong supplementation and follow-up required of any malabsorptive operation.

A pre-conversion upper GI evaluation (and often endoscopy and/or pH and manometry testing when reflux is the indication) is essential to confirm the indication and map the anatomy (Thá Nassif et al., 2025).

The operation is performed under general anesthesia using a minimally invasive (laparoscopic or robotic) approach. The existing sleeve is reshaped into a small gastric pouch, the small intestine is divided, and a Roux limb is connected to the pouch (gastrojejunostomy) and reconnected further down (jejunojejunostomy). Because the sleeve was created in a prior operation, the surgeon must carefully lyse adhesions, but the presence of an existing tubular stomach can make pouch creation more straightforward than in a primary bypass (Dang et al., 2023). Revisional RYGB is more complex than primary surgery owing to adhesions and prior surgical changes, which raises the complication rate somewhat without adversely affecting mortality (Rapolti et al., 2024). For these reasons, these cases are best performed at experienced, high-volume centers.

You can watch the main steps of this operation in our Sleeve to Gastric Bypass Conversion: 4-Minute Real Surgery Breakdown video.

Sleeve-to-bypass conversion is safe but carries a somewhat higher risk than primary surgery because of adhesions and reoperative anatomy, and this should be discussed candidly. In the largest national analysis, the overall serious-complication rate was 7.2% — higher than a primary bypass, but with mortality that was not significantly different after adjusting for comorbidities (Dang et al., 2023). A single-center series reported a major complication rate of 5.2%, though patients converted for a stricture had a substantially higher complication rate (around 54%) than those converted for GERD (about 9%) — an important counseling point for stricture patients (Frieder et al., 2026). A large meta-analysis reported serious adverse events in 16.4% within 30 days and 11.4% after 30 days, with a reoperation rate of 6.7% (Rapolti et al., 2024).

The most important procedure-specific long-term risks of any RYGB are marginal (anastomotic) ulcer, internal hernia, anastomotic stricture, and small-bowel obstruction, along with the nutritional consequences of a malabsorptive operation. New-onset iron-deficiency anemia and deficiencies of calcium, vitamin B12, folate, and fat-soluble vitamins are possible and require lifelong monitoring and supplementation (Yorke et al., 2017). One nuance worth noting: in a multi-institutional study, patients converted for GERD had more late reoperations over 4 years than those converted for weight regain (14% vs 4%), so reflux-indication patients warrant closer long-term follow-up (Kaoukabani et al., SOARD, 2025).

Recovery mirrors a primary gastric bypass but with the added considerations of reoperative surgery. Most patients have a short hospital stay followed by a staged diet progression. Early, progressive walking reduces clot risk, and most weight loss occurs over the first 12–18 months. Patients follow the staged bariatric diet and begin a lifelong supplementation and follow-up routine immediately.

Expectations should be framed honestly by the reason for conversion. For reflux, the results are excellent: more than 75% of patients have resolution of GERD symptoms at 1 year (Kaoukabani et al., 2025), and a large meta-analysis found symptom remission in 79.7% at 1 year and 91.3% at 2 years (Rapolti et al., 2024). For weight regain, conversion produces meaningful but more modest additional weight loss than a primary operation — patients should understand that sleeve-to-bypass typically falls short of the weight loss seen with a first-time procedure (Marwaha et al., 2025). In weight-regain patients specifically, durable results are achievable, with excess BMI loss sustained above 48% beyond 4 years in one series (Frieder et al., 2026). Importantly, patients should know that a bypass is not the only option after a failed sleeve: network meta-analyses consistently identify SADI-S as producing greater additional weight loss, though RYGB remains the clear winner when reflux is the problem (Małczak et al., 2025; Salman et al., World Journal of Surgery, 2024).

More in Sleeve Gastrectomy Revisions

Related procedures: Sleeve Gastrectomy to SADI-S Conversion, Sleeve Gastrectomy to Duodenal Switch Conversion, Sleeve to OAGB Conversion, Sleeve Gastrectomy to Magnetic Duodeno-Ileostomy Conversion, Re-Sleeve Gastrectomy, Hiatal Hernia Repair After Sleeve Gastrectomy. Related primary operations: Sleeve Gastrectomy, Gastric Bypass. For an overview of all options, see Revisional Bariatric Surgery.

Conditions treated: Weight Regain, Inadequate Weight Loss, Acid Reflux, Stomach Narrowing (Stricture) After Bariatric Surgery, Reflux After Sleeve Gastrectomy, Erosive (Reflux) Esophagitis.

Revisional gastric bypass after a sleeve is a technically demanding operation — adhesions, altered anatomy, the need to fashion a small pouch from an existing sleeve, and the judgment of how to address reflux versus weight all affect safety and outcomes, and results are strongly tied to surgeon experience and center volume (Dang et al., 2023). Dr. de la Cruz-Muñoz is a board-certified metabolic and bariatric surgeon who performs the full spectrum of revision and conversion procedures — from the reflux-correcting sleeve-to-bypass through the malabsorptive conversions (SADI-S and BPD/DS) that few surgeons offer — using minimally invasive and robotic techniques. Every sleeve conversion begins with a complete anatomical and multidisciplinary evaluation, including an upper GI study and, when reflux is the issue, objective testing, so the operation is matched precisely to each patient's anatomy, reflux status, BMI, and metabolic needs.

Dr. de la Cruz-Muñoz has been performing bariatric surgery for over 25 years and has completed more than 9,000 bariatric operations — a volume few surgeons reach.

Research and Publications

Dr. de la Cruz-Muñoz's published and presented work on this topic includes:

• Invited lecture: “Weight Regain and GERD after Sleeve Gastrectomy.” ASMBS Annual Meeting, Washington, D.C., 2025.
• Monzon Canales EJ, Ribieras AJ, de la Cruz-Muñoz N. Prospective long-term outcomes in patients undergoing laparoscopic sleeve gastrectomy with and without hiatal hernia repair. ASMBS Annual Meeting, 2024 (Surgery for Obesity and Related Diseases 20(6):S117).

For weight-regain conversions, expect meaningful but moderate additional weight loss. A retrospective cohort reported average excess weight loss of about 40% at 1 year and 37% at 2 years after sleeve-to-bypass conversion for weight (Marwaha et al., 2025). Multi-institutional data show total weight loss of about 13–16% after conversion, depending on indication (Kaoukabani et al., 2025). Two predictors forecast a below-average response — a BMI over 40 kg/m² at the time of conversion and more than 40% excess weight loss already achieved after the original sleeve — and these patients should discuss alternatives such as a more malabsorptive conversion or adjunctive anti-obesity medication (Marwaha et al., 2025). Even a 40% excess weight loss is substantially greater than the roughly 13% expected from GLP-1 medications alone for weight regain after bariatric surgery (Marwaha et al., 2025). Individual results depend on starting BMI, the reason for conversion, and adherence.

The most reliable benefit of converting a sleeve to a gastric bypass is control of reflux: in a multicenter series, most patients converted for GERD had their reflux symptoms resolve or improve and were able to stop or reduce acid medication (Parmar et al., Obesity Surgery, 2017). The bypass also removes the high-pressure sleeve that drives reflux and can heal reflux-related esophagitis.

Metabolic gains are more modest when the conversion is done for weight regain. Patients whose diabetes, blood pressure or cholesterol worsened as weight returned often see these improve again as weight comes down, but the response varies, and the same study found little additional weight loss on average when the main reason for conversion was reflux (Parmar et al., Obesity Surgery, 2017). Your expected metabolic benefit is discussed individually based on your current conditions and the reason for conversion.

Durable results require a lifelong plan: protein-prioritized nutrition, strict daily supplementation, regular physical activity, and multidisciplinary behavioral follow-up. The malabsorptive component of the bypass supports durability, but that advantage is only realized with consistent follow-up. Because higher-BMI patients (>40 kg/m²) are predicted to lose less after a sleeve-to-bypass conversion, these patients may benefit from a more malabsorptive conversion or from layering on anti-obesity medications (including GLP-1 therapy), and future work is examining GLP-1 augmentation specifically in this setting (Marwaha et al., 2025).

This is the central strength of the bypass and the most common reason sleeve patients are converted. A sleeve creates a narrow, high-pressure gastric tube that both perpetuates pre-existing reflux and causes de novo GERD in a large share of patients (Thá Nassif et al., 2025). RYGB is the gold-standard surgical treatment for refractory GERD after a sleeve because it creates a small, low-pressure, rapid-emptying pouch and diverts acid and bile away from the esophagus (Thá Nassif et al., 2025). A randomized trial confirmed that bypass is objectively superior to the sleeve for preventing acid reflux and new-onset esophagitis (Lorentzen et al., 2021). Symptom resolution is high (60–100% across studies; ~80–91% in meta-analysis), though objective testing shows improvement in roughly half of patients, so realistic counseling and, when needed, objective pre- and post-op evaluation are important (Rapolti et al., 2024; Cymbal et al., SOARD, 2026). For any sleeve patient whose dominant problem is reflux, bypass — not re-sleeve or SADI-S — is the preferred conversion.

Sleeve-to-bypass is one of several conversion pathways after a failed sleeve; the correct choice depends on whether the problem is reflux, weight, or both, and on BMI and metabolic disease:

• Sleeve → Roux-en-Y gastric bypass (this page) — the gold standard when reflux is the dominant problem, and a proven, low-complication option for weight regain (Clapp et al., 2024; Dang et al., 2023).

• Sleeve → SADI-S — ranked highest for additional weight loss after a sleeve in network meta-analyses, with comparable complication rates; best when weight is the issue and reflux is not (Małczak et al., 2025; Salman et al., 2024).

• Sleeve → one-anastomosis gastric bypass (OAGB) — produces modestly greater weight loss than RYGB but is associated with more postoperative reflux (Dantas et al., Obesity Surgery, 2022).

• Sleeve → BPD/DS — among the most powerful conversions for higher-BMI patients and maximal diabetes remission.

• Re-sleeve (repeat sleeve gastrectomy) — the lowest-morbidity option, but with the least durable weight loss and the highest rate of reflux, generally reserved for select cases (Al-Sabah et al., SOARD, 2020; Salman et al., 2024).

See Revisional Bariatric Surgery and the dedicated pages for each pathway.

As with any weight-loss operation, a portion of the weight lost is lean mass, so protecting muscle is important. A high daily protein intake (generally ≥60–80 g/day), resistance training, and body-composition monitoring help ensure the weight lost is predominantly fat, preserving metabolic rate and supporting durable results. Because the bypass adds malabsorption, meeting protein targets through diet and supplements is especially important.

Coverage for revision surgery is more restrictive and variable than for primary procedures. Many plans require documentation of the original sleeve, objective evidence of the problem being treated — such as endoscopy or pH testing confirming refractory GERD, or documented weight regain/inadequate weight loss — and a repeat preoperative work-up; some policies will not cover a second weight-loss procedure performed solely for weight-loss failure, though documented GERD or a functional complication often strengthens the medical-necessity case. Our team handles the documentation needed to establish medical necessity.

Sleeve-to-bypass conversion requires a more detailed work-up than a first operation. This includes an upper GI contrast study and/or endoscopy to map the anatomy and assess for a stricture, dilated sleeve, or hiatal hernia, and — when reflux is the indication — objective testing with pH monitoring and esophageal manometry to confirm the diagnosis and document severity (Thá Nassif et al., 2025). A complete multidisciplinary evaluation (nutritional, behavioral/psychosocial, and medical optimization), baseline nutritional labs, smoking cessation (especially important given marginal-ulcer risk after bypass), and cardiac, pulmonary, and sleep-apnea evaluations are arranged as indicated.

Patients follow the staged bariatric diet (clear liquids → full liquids → pureed → soft → regular textures) over several weeks, with emphasis on adequate protein, hydration, and small portions. Because the bypass is both restrictive and malabsorptive, lifelong supplementation and routine lab monitoring of iron, calcium, vitamin B12, folate, and fat-soluble vitamins, plus adequate protein intake, are required to prevent deficiency, with ongoing dietitian follow-up. Iron-deficiency anemia in particular has been reported after conversion and should be watched for (Yorke et al., 2017).

Early walking begins immediately after surgery. Light activity continues through week 2. Resistance training typically begins at week 4–6. Early, progressive walking reduces clot risk and speeds recovery. Patients gradually resume normal activity over the first few weeks, avoid heavy lifting during initial healing, and transition into a combined aerobic and resistance-training program to preserve lean muscle mass and support durable weight loss.

Most patients who travel for sleeve-to-bypass conversion have severe reflux. Bringing endoscopy reports and any pH testing speeds up planning. Expect to stay in Miami for approximately one week, with reflux and nutrition follow-up done virtually.